Britain’s first large-scale trial of medicinal cannabis held back due to ethical objections

Plans to hold Britain’s first large-scale trial of medicinal cannabis had to be dramatically scaled back following ethical objections, The Mail on Sunday can reveal.

Earlier this month it emerged that Harley Street firm LVL Health had obtained approval for a ‘feasibility study’ on 100 patients.

The plan was to see if vaping ‘whole flower’ cannabis could alleviate chronic pain, with LVL hoping that this would lead straight to a 5,000-people trial.

The move, however, was rejected by an ethics panel.

About one in three adults in England have chronic pain – defined as lasting more than three months.